Sheng Zhang
Sheng Zhang
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies | Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, bladder urachal carcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, neoplasm | Recruiting | Phase 2 | 2025-12-30 | NCT07309770 | |
| Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Not applicable | 2025-09-15 | NCT07164950 | |
| Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure | Multiple Advanced Tumors After PD-1 Therapy Failure | Not yet recruiting | Phase 2 | 2025-07-31 | NCT07095803 | |
| Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors | Advanced Solid Tumors | Recruiting | Phase 2 | 2025-07-01 | NCT07046650 |